KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Globus Medical (GMED) Cash from Financing Activities (2016 - 2025)

Globus Medical (GMED) has disclosed Cash from Financing Activities for 15 consecutive years, with $13.2 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Cash from Financing Activities fell 77.88% year-over-year to $13.2 million, compared with a TTM value of -$679.2 million through Dec 2025, down 2352.2%, and an annual FY2025 reading of -$679.2 million, down 2352.2% over the prior year.
  • Cash from Financing Activities was $13.2 million for Q4 2025 at Globus Medical, up from -$32.0 million in the prior quarter.
  • Across five years, Cash from Financing Activities topped out at $59.7 million in Q4 2024 and bottomed at -$635.4 million in Q1 2025.
  • Average Cash from Financing Activities over 5 years is -$49.7 million, with a median of $4.5 million recorded in 2022.
  • The sharpest move saw Cash from Financing Activities skyrocketed 1428.54% in 2022, then plummeted 4036.09% in 2024.
  • Year by year, Cash from Financing Activities stood at -$1.0 million in 2021, then surged by 1428.54% to $13.6 million in 2022, then crashed by 1845.79% to -$237.3 million in 2023, then skyrocketed by 125.18% to $59.7 million in 2024, then plummeted by 77.88% to $13.2 million in 2025.
  • Business Quant data shows Cash from Financing Activities for GMED at $13.2 million in Q4 2025, -$32.0 million in Q3 2025, and -$24.9 million in Q2 2025.